Inhibition of farnesyl protein-transferase in neuroblastoma cells by α-hydroxyfarnesylphosphonate

被引:0
|
作者
Girgert, R [1 ]
Hohnecker, A [1 ]
Wittrock, J [1 ]
Schweizer, P [1 ]
机构
[1] Univ Tubingen, Oncol Lab, Dept Pediat Surg, D-72076 Tubingen, Germany
关键词
farnesyl-transferase; membrane anchorage; neuroblastoma; ras;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogenic Ras is responsible for malignant transformation in a variety of tumors. Farnesylation of Ras by farnesyl-protein-transferase (FPTase) is neccessary for membrane localization of Ras-proteins, a prerequisite for its biological activity. Although mutations in ras genes are rare in neuroblastoma inactivation of Ras by inhibition of the FPTase is of interest in neuroblastoma. In this tumor, amplification of N-myc is frequently observed and expression of N-myc is induced via Ras signaling. Farnesyl-protein-transferase of neuroblastoma cells is inhibited by alpha-hydroxyfarnesylphosphonate. In homogenates of the cell line SK-N-AS an ID50 = 6.5 mu M is estimated, in SK-N-SH the ID50 is 3.4 mu M. The consequences of the inhibition of FPTase on the membrane localization was examined by immunoblots. Western blots of membrane proteins analysed with H-ras and N-ras specific antibodies revealed that H-ms protein is more sensitive to the inhibition of FPTase than N-ras protein. After culturing neuroblastoma cells for 24 hrs in the presence of 20 mu M a-hydroxyfarnesylphosphonate H-ras protein completely dissappeared from the membrane fraction whereas N-ras protein was only affected by 50 %. K-ras was not detectable on Western blots of three neuroblastoma cell lines. The experiments showed that FPTase inhibitors are effective in neuroblastoma cells but for, complete inactivation of N-ras stronger conditions are required than for H-ras.
引用
收藏
页码:2959 / 2962
页数:4
相关论文
共 50 条
  • [31] ISOPRENYLATION OF THE RAS ONCOGENE PROTEIN BY A FARNESYL-PROTEIN TRANSFERASE
    GIBBS, JB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 9 - BTEC
  • [32] Benzocycloheptapyridine farnesyl protein transferase inhibitors: Effects of substitution at position 5 and 6 on enzyme inhibition
    delRosario, JD
    Remiszewski, SW
    Bishop, WR
    Doll, RJ
    James, L
    Kirschmeier, P
    Nafissi, M
    Njoroge, FG
    Petrin, J
    Pinto, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 198 - MEDI
  • [33] PSEUDOPEPTIDE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE
    GRAHAM, SL
    DESOLMS, SJ
    GIULIANI, EA
    KOHL, NE
    MOSSER, SD
    OLIFF, AI
    POMPLIANO, DL
    RANDS, E
    BRESLIN, MJ
    DEANA, AA
    GARSKY, VM
    SCHOLZ, TH
    GIBBS, JB
    SMITH, RL
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) : 725 - 732
  • [34] PSEUDOPEPTIDE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE
    DESOLMS, SJ
    GIULIANI, EA
    GRAHAM, SL
    ANTHONY, NJ
    GOMEZ, RP
    HOLTZ, WJ
    KOHL, NE
    LEE, TJ
    MOSSER, SD
    OLIFF, AI
    POMPLIANO, DL
    RANDS, E
    SCHOLZ, TH
    GIBBS, JB
    SMITH, RL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 277 - MEDI
  • [35] On the stereochemical course of human protein-farnesyl transferase
    Mu, YQ
    Omer, CA
    Gibbs, RA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (08) : 1817 - 1823
  • [36] Farnesyl protein transferase inhibitory components of Polygonum multiflorum
    Kwon, Byoung-Mog
    Kim, Sung-Hoon
    Baek, Nam-In
    Lee, Sa Im
    Kim, Eun Jeong
    Yang, Jae Heon
    Chae, Byeong Suk
    Lee, Jae Hyeok
    Park, Hee Wook
    Park, Jeong-Suk
    Kim, Dae Keun
    ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (04) : 495 - 499
  • [37] Diaryl ether inhibitors of farnesyl-protein transferase
    MacTough, SC
    DeSolms, SJ
    Shaw, AW
    Abrams, MT
    Ciccarone, TR
    Davide, JP
    Hamilton, KA
    Hutchinson, JH
    Koblan, KS
    Kohl, NE
    Lobell, RB
    Robinson, RG
    Graham, SL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) : 1257 - 1260
  • [38] Farnesyl protein transferase inhibitors as potential cancer chemopreventives
    Kelloff, GJ
    Lubet, RA
    Fay, JR
    Steele, VE
    Boone, CW
    Crowell, JA
    Sigman, CC
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (04) : 267 - 282
  • [39] POLYISOPRENYLATION OF RAS INVITRO BY A FARNESYL-PROTEIN TRANSFERASE
    SCHABER, MD
    OHARA, MB
    GARSKY, VM
    MOSSER, SD
    BERGSTROM, JD
    MOORES, SL
    MARSHALL, MS
    FRIEDMAN, PA
    DIXON, RAF
    GIBBS, JB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (25) : 14701 - 14704
  • [40] Farnesyl protein transferase inhibitory components of Polygonum multiflorum
    Byoung-Mog Kwon
    Sung-Hoon Kim
    Nam-In Baek
    Sa Im Lee
    Eun Jeong Kim
    Jae Heon Yang
    Byeong Suk Chae
    Jae Hyeok Lee
    Hee Wook Park
    Jeong-Suk Park
    Dae Keun Kim
    Archives of Pharmacal Research, 2009, 32 : 495 - 499